go back

Diphenhydramine, Oral

Alaska rates for HCPCS Q0163

Diphenhydramine HCl, 50 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at time of chemotherapy treatment not to exceed a 48-hour dosage regimen

Rates data updated July 2026.

Facilitymedian $0 · 10th–90th $0$50%20%10th90th$0Professionalmedian $0 · 10th–90th $0$00%50%90th$0$0.0$0.1$0.5$2.0$10.0$50.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$2.51
Median
$3.63
Typical High
$6.03
Aetna
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.03
Cigna
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.02
Moda Health
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.03
Typical High
$0.52
Moda Health
Setting
Professional
Modifier
Global
Typical Low
$60.26
Median
$60.26
Typical High
$60.26
Premera BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.03
Median
$0.03
Typical High
$0.04
Premera BCBS
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.02
Providence
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.03
Typical High
$0.52
Providence
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.52
United
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.05